Study summary
A triple-hormone injection lowered HbA1c by about 2 points and weight by 15%
15.3%weight loss with the highest dose, vs 2.6% with placebo
What was tested
Retatrutide, a weekly injection that acts on GIP, GLP-1 and glucagon receptors, against placebo for 40 weeks in type 2 diabetes managed with diet and exercise.
What they found
- HbA1c fell 1.94 points with 12 mg vs 0.81 with placebo.
- Weight fell 15.3% vs 2.6%.
- Side effects were mostly stomach upset; no severe low blood sugar.
What it means
Retatrutide may offer the largest blood sugar and weight effects of any diabetes drug so far.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.